Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1Diabetes MellitusHypoglycemic AgentsBlood GlucoseDiabetic NeuropathiesHemoglobin A, GlycosylatedDiabetic NephropathiesInsulinCase-Control StudiesObesityRisk FactorsDiabetes ComplicationsDiabetes Mellitus, ExperimentalDiabetes, GestationalGlucose Tolerance TestHyperglycemiaDiabetic AngiopathiesInsulin ResistanceDiabetic RetinopathyIslets of LangerhansPrevalenceGlucoseDiabetic KetoacidosisGlucose IntoleranceBody Mass IndexPregnancy in DiabeticsStreptozocinHypertensionC-PeptideAlbuminuriaFollow-Up StudiesProspective StudiesCardiovascular DiseasesCohort StudiesPrediabetic StateFastingIncidenceTime FactorsHypoglycemiaSulfonylurea CompoundsInsulin-Secreting CellsDiabetes InsipidusDiabetic DietMetforminBlood Glucose Self-MonitoringRetrospective StudiesBiological MarkersTreatment OutcomeReference ValuesCross-Sectional StudiesBlood PressureAge FactorsGlutamate DecarboxylaseTriglyceridesRisk AssessmentThiazolidinedionesGlucose Clamp TechniqueLipidsComorbidityBody WeightPregnancyMice, Inbred NODSex FactorsJapanMetabolic Syndrome XRats, Inbred OLETFMultivariate AnalysisRats, Inbred BBUnited StatesHyperlipidemiasAlloxanRegression AnalysisLogistic ModelsIslet Amyloid PolypeptideInsulin Infusion SystemsFructosamineGlucagonAsian Continental Ancestry GroupDipeptidyl-Peptidase IV InhibitorsIndians, North AmericanGenotypeCoronary Artery DiseaseDiabetic FootOdds RatioGenetic Predisposition to DiseaseHyperinsulinismAutoantibodiesPancreasProinsulinDyslipidemiasGlucagon-Like Peptide 1Predictive Value of TestsProportional Hazards ModelsGlycosuriaSelf CareAnalysis of VarianceCoronary DiseaseArizonaKidney Failure, Chronic